Strs Ohio Y M Abs Therapeutics, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 43,400 shares of YMAB stock, worth $353,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,400

Previous 43,400 -0.0%

Holding current value

$353,710

Previous $524,000 8.59%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$11.6 - $17.25 $96,280 - $143,175	8,300 Added 23.65%	43,400 $524,000
Q1 2024 May 13, 2024	SELL	$6.57 - $18.69 $286,452 - $814,884	-43,600 Reduced 55.4%	35,100 $570,000
Q4 2023 Jan 30, 2024	SELL	$4.88 - $7.42 $50,264 - $76,426	-10,300 Reduced 11.57%	78,700 $536,000
Q3 2023 Oct 26, 2023	BUY	$4.86 - $7.23 $72,414 - $107,727	14,900 Added 20.11%	89,000 $485,000
Q2 2023 Jul 31, 2023	SELL	$5.68 - $10.34 $424,296 - $772,398	-74,700 Reduced 50.2%	74,100 $503,000
Q1 2023 Aug 02, 2023	BUY	$2.83 - $5.11 $211,401 - $381,717	74,700 Added 100.81%	148,800 $745,000
Q1 2023 Apr 27, 2023	BUY	$2.83 - $5.11 $110,087 - $198,779	38,900 Added 35.4%	148,800 $745,000
Q4 2022 Jan 26, 2023	BUY	$3.0 - $15.17 $242,400 - $1.23 Million	80,800 Added 277.66%	109,900 $536,000
Q3 2022 Oct 27, 2022	BUY	$13.96 - $19.67 $34,900 - $49,175	2,500 Added 9.4%	29,100 $419,000
Q2 2022 Jul 25, 2022	BUY	$8.22 - $15.13 $12,330 - $22,695	1,500 Added 5.98%	26,600 $402,000
Q1 2022 Apr 21, 2022	BUY	$6.55 - $17.42 $164,405 - $437,242	25,100 New	25,100 $298,000
Q2 2021 Jul 26, 2021	SELL	$25.45 - $37.64 $386,840 - $572,128	-15,200 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$29.16 - $51.96 $40,824 - $72,744	1,400 Added 10.14%	15,200 $459,000
Q3 2020 Dec 14, 2020	SELL	$35.13 - $43.62 $112,416 - $139,584	-3,200 Reduced 18.82%	13,800 $529,000
Q2 2020 Jul 23, 2020	SELL	$23.66 - $49.53 $156,156 - $326,898	-6,600 Reduced 27.97%	17,000 $734,000
Q4 2019 Jan 24, 2020	BUY	$23.81 - $33.78 $35,715 - $50,670	1,500 Added 6.79%	23,600 $737,000
Q3 2019 Oct 21, 2019	BUY	$21.57 - $31.37 $435,714 - $633,674	20,200 Added 1063.16%	22,100 $575,000
Q4 2018 Jan 23, 2019	BUY	$15.41 - $28.92 $29,279 - $54,948	1,900 New	1,900 $38,000

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account